Senior insider sale
See Remarks at CRESCENT BIOPHARMA, INC. — senior position signals high conviction
$458.7K
25.70K shares
What this filing means
MCNEILL JONATHAN plans to sell 25.70K shares of CRESCENT BIOPHARMA, INC. valued at approximately $458.7K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 9/17/2026ACC: 0001628280-26-062526
Officer· See Remarks
Since Jun 2025
25.70K
Shares to sell
$458.7K
Approx. market value
8.39K
Acquired (3 months)
1
Planned
2 completed
Securities Acquired — Last 3 Months1
Restricted Stock Unit Vesting
Services rendered
9/17/2026
8.39KTotal acquired8.39K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
9/17/2026 | Restricted Stock Unit Vesting Services rendered | 8.39K | — |
| Total | 8.39K | ||
Planned & Completed Dispositions3
Completed
—Completed
Units to sell
731.00
Market value
$13.1K
9/16/2026
—Completed
Units to sell
20.55K
Market value
$369.8K
6/22/2026
Planned — Approximate Date
NasdaqPlanned
Units to sell
4.42K
Market value
$75.8K
9/18/2026
Total
Units
25.70K
Value
$458.7K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
9/16/2026 | 731.00 | $13.1K | — | Completed |
6/22/2026 | 20.55K | $369.8K | — | Completed |
| Planned — Approximate Date | ||||
9/18/2026 | 4.42K | $75.8K | Nasdaq | Planned |
| Total | 25.70K | $458.7K | ||